Taeguk Pharmaceutical Launches 'Moacure Eye Drops' for Eye Health During Seasonal Changes View original image

[Asia Economy Reporter Lee Gwanju] Taeguk Pharmaceutical announced on the 31st that it has launched 'Moacure Eye Drops,' an ophthalmic treatment for eye health during the changing seasons. It helps treat various eye conditions such as conjunctivitis (epidemic keratoconjunctivitis), stye, eyelid chapping, and eye itching.


During the changing seasons, outdoor activities increase, making eyes more exposed to pollen, yellow dust, and fine dust. Various pollutants can cause allergic or inflammatory reactions, adversely affecting eye health, so caution is necessary.


Moacure Eye Drops contain the antibacterial ingredient 'sulfamethoxazole' to treat bacterial infections, and the antihistamine ingredient 'chlorpheniramine maleate' to suppress allergic reactions and relieve eye itching.


Moacure Eye Drops should be applied 2-3 drops per use, 5-6 times a day. It is an over-the-counter drug and can be purchased at pharmacies without a prescription.



A Taeguk Pharmaceutical official said, "Recently, the increase in the use of electronic devices such as smartphones and computers has led to more people suffering from eye diseases, and especially during the changing seasons, many people suffer from seasonal allergic conjunctivitis," adding, "Rubbing or touching itchy eyes can cause damage to the eye surface, so it is better to treat symptoms with appropriate medication."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing